These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32113869)

  • 1. Emerging extensively drug-resistant bacteria (eXDR) in France in 2018.
    Colomb-Cotinat M; Soing-Altrach S; Leon A; Savitch Y; Poujol I; Naas T; Cattoir V; Berger-Carbonne A; Dortet L;
    Med Mal Infect; 2020 Nov; 50(8):715-722. PubMed ID: 32113869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency of different control measures for preventing carbapenemase-producing enterobacteria and glycopeptide-resistant
    Fournier S; Desenfant L; Monteil C; Nion-Huang M; Richard C; Jarlier V;
    Euro Surveill; 2018 Feb; 23(8):. PubMed ID: 29486831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. French recommendations for the prevention of 'emerging extensively drug-resistant bacteria' (eXDR) cross-transmission.
    Lepelletier D; Berthelot P; Lucet JC; Fournier S; Jarlier V; Grandbastien B;
    J Hosp Infect; 2015 Jul; 90(3):186-95. PubMed ID: 25986165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptomatic carriage of extensively drug-resistant bacteria (eXDR), a simple way to assess spontaneous clearance.
    Farfour E; Si Larbi AG; Couturier J; Lecuru M; Decousser JW; Renvoise A; Faibis F; Lawrence C; Nerome S; Lecointe D;
    J Hosp Infect; 2020 Apr; 104(4):503-507. PubMed ID: 31874205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection control and risk factors for acquisition of carbapenemase-producing enterobacteriaceae. A 5 year (2011-2016) case-control study.
    Segagni Lusignani L; Presterl E; Zatorska B; Van den Nest M; Diab-Elschahawi M
    Antimicrob Resist Infect Control; 2020; 9(1):18. PubMed ID: 31988746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term control of carbapenemase-producing Enterobacteriaceae at the scale of a large French multihospital institution: a nine-year experience, France, 2004 to 2012.
    Fournier S; Monteil C; Lepainteur M; Richard C; Brun-Buisson C; Jarlier V; Ap-Hp Outbreaks Control Group C
    Euro Surveill; 2014 May; 19(19):. PubMed ID: 24852956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.
    Nicolas-Chanoine MH; Vigan M; Laouénan C; Robert J;
    Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):383-393. PubMed ID: 30488368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of a regional outbreak of vanA glycopeptide-resistant Enterococcus faecium, Eastern France, 2004-2009.
    Henard S; Gendrin V; Simon L; Jouzeau N; Vernier N; Thiolet JM; Coignard B; Rabaud C
    Int J Hyg Environ Health; 2011 Jun; 214(3):265-70. PubMed ID: 21330205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-series modelling for the quantification of seasonality and forecasting antibiotic-resistant episodes: application to carbapenemase-producing Enterobacteriaceae episodes in France over 2010-20.
    Roux J; Nekkab N; Colomb-Cotinat M; Astagneau P; Crépey P
    J Antimicrob Chemother; 2021 Jan; 76(1):226-232. PubMed ID: 32929455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Glycopeptide-resistant Enterococcus outbreak in an ICU with simultaneous circulation of two different clones].
    Delamare C; Lameloise V; Lozniewski A; Perrin M; Baudin C; Sellies J; Dumay M; Bemer M;
    Pathol Biol (Paris); 2008; 56(7-8):454-60. PubMed ID: 18835105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and accurate eXDR screening: use Xpert Carba-R® with FecalSwab®.
    Farfour E; Lomont A; Fihman V; Lecuru M; Hüssler S; Ouzani S; Zahar JR; Dortet L;
    Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115279. PubMed ID: 33387895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbapenemase-producing Enterobacterales outbreak: Another dark side of COVID-19.
    Farfour E; Lecuru M; Dortet L; Le Guen M; Cerf C; Karnycheff F; Bonnin RA; Vasse M; Lesprit P;
    Am J Infect Control; 2020 Dec; 48(12):1533-1536. PubMed ID: 33011336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A 6-year study of glycopeptides-resistant enterococci in 3 intensive care units of the University Hospital of Montpellier].
    Godreuil S; Marchandin H; Boulier A; Boumzebra A; Campos J; Jean-Pierre H
    Pathol Biol (Paris); 2007 Nov; 55(8-9):418-23. PubMed ID: 17905540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outbreak in a haematology unit involving an unusual strain of glycopeptide-resistant Enterococcus faecium carrying both vanA and vanB genes.
    Marcadé G; Micol JB; Jacquier H; Raskine L; Donay JL; Nicolas-Viaud S; Rouveau M; Ribaud P; Dombret H; Leclercq R; Cambau E
    J Antimicrob Chemother; 2014 Feb; 69(2):500-5. PubMed ID: 24092659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the role of inter-facility patient transfer in the spread of carbapenemase-producing Enterobacteriaceae: the case of France between 2012 and 2015.
    Nekkab N; Crépey P; Astagneau P; Opatowski L; Temime L
    Sci Rep; 2020 Sep; 10(1):14910. PubMed ID: 32913244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends and molecular characteristics of carbapenemase-producing Enterobacteriaceae in Japanese hospital from 2006 to 2015.
    Eda R; Nakamura M; Takayama Y; Maehana S; Nakano R; Yano H; Kitasato H
    J Infect Chemother; 2020 Jul; 26(7):667-671. PubMed ID: 32222331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of meticillin-resistant Staphylococcus aureus and carbapenemase-producing Enterobacteriaceae in Danish emergency departments - evaluation of national screening guidelines.
    Skjøt-Arkil H; Mogensen CB; Lassen AT; Johansen IS; Chen M; Petersen P; Andersen KV; Ellermann-Eriksen S; Møller JM; Ludwig M; Fuglsang-Damgaard D; Nielsen FE; Petersen DB; Jensen US; Rosenvinge FS
    J Hosp Infect; 2020 Jan; 104(1):27-32. PubMed ID: 31494129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of carbapenemase-producing Enterobacteriaceae in a pediatric hospital in a country with high endemicity.
    Castagnola E; Tatarelli P; Mesini A; Baldelli I; La Masa D; Biassoni R; Bandettini R
    J Infect Public Health; 2019; 12(2):270-274. PubMed ID: 30477920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Germs of thrones - spontaneous decolonization of Carbapenem-Resistant Enterobacteriaceae (CRE) and Vancomycin-Resistant Enterococci (VRE) in Western Europe: is this myth or reality?
    Davido B; Moussiegt A; Dinh A; Bouchand F; Matt M; Senard O; Deconinck L; Espinasse F; Lawrence C; Fortineau N; Saleh-Mghir A; Caballero S; Escaut L; Salomon J
    Antimicrob Resist Infect Control; 2018; 7():100. PubMed ID: 30123500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and risk factors of rectal colonization of carbapenemase-producing Enterobacteriaceae among high-risk patients from ICU and HSCT wards in a university hospital.
    Yan L; Sun J; Xu X; Huang S
    Antimicrob Resist Infect Control; 2020 Sep; 9(1):155. PubMed ID: 32967718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.